FSD Pharma Inc.
NASDAQ:HUGE
0.0899 (USD) • At close August 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 2.743 | 16.98 | 35.26 | 17.525 | 6.073 | 15.517 | 3.769 | 0.007 | 0 |
| Short Term Investments
| 0.752 | 0.023 | 0.158 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 3.495 | 17.004 | 35.418 | 17.525 | 6.073 | 15.517 | 3.769 | 0.007 | 0 |
| Net Receivables
| 7.417 | 0.374 | 0.501 | 0.161 | 1.585 | 0.728 | 0.234 | 0 | 0.002 |
| Inventory
| 0 | 0 | 0.014 | 0 | 0.722 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 0.155 | 0.472 | 10.014 | 9.18 | 0.329 | 0.326 | 0.562 | 0 | 0 |
| Total Current Assets
| 11.029 | 17.85 | 45.933 | 26.866 | 8.709 | 16.571 | 4.284 | 0.007 | 0.002 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 0.12 | 0.261 | 0.168 | 0 | 9.134 | 8.914 | 6.594 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 5.356 | 12.04 | 16.202 | 13.424 | 17.117 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 5.356 | 12.04 | 16.202 | 13.424 | 17.117 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0.909 | 0.828 | 0.66 | 1.677 | 9.019 | 13.263 | 0 | 0 | 0 |
| Tax Assets
| -5.356 | 0 | 0.022 | 0 | 0.045 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 5.328 | 7.432 | -0.022 | -0 | -0.045 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets
| 6.357 | 20.56 | 17.03 | 15.101 | 35.269 | 22.177 | 6.594 | 0 | 0 |
| Total Assets
| 17.385 | 38.411 | 62.963 | 41.967 | 43.978 | 38.748 | 10.878 | 0.007 | 0.002 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 3.241 | 2.76 | 2.996 | 2.063 | 3.42 | 1.28 | 1.007 | 0.028 | 0.037 |
| Short Term Debt
| 0.339 | 0.478 | 0.425 | 0.431 | 1.504 | 0 | 0 | 0 | 0.018 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| -3.241 | 0 | 4.515 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 0.962 | 4.592 | 5.28 | 3.085 | 2.026 | 0 | 0 | 0.033 | 0.006 |
| Total Current Liabilities
| 4.542 | 7.83 | 8.701 | 5.58 | 6.95 | 1.28 | 1.007 | 0.061 | 0.061 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 0 | 0.038 | 0.131 | 0.079 | 0.112 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 0 | 0.038 | 0.131 | 0.079 | 0.112 | 1.28 | 1.007 | 0.028 | 0.055 |
| Total Liabilities
| 4.542 | 7.868 | 8.832 | 5.659 | 7.062 | 1.28 | 1.007 | 0.061 | 0.061 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 137.074 | 143.411 | 152.325 | 103.208 | 75.036 | 50.012 | 10.335 | 1.068 | 1.056 |
| Retained Earnings
| -157.1 | -144.164 | -126.154 | -90.869 | -60.109 | -19.46 | -3.336 | -1.301 | -1.256 |
| Accumulated Other Comprehensive Income/Loss
| 3.125 | 0.653 | 0.24 | 0.208 | -0.086 | -0.183 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 32.881 | 30.643 | 27.721 | 23.762 | 97.111 | 7.099 | 2.873 | 0.178 | 0.142 |
| Total Shareholders Equity
| 13.169 | 30.542 | 54.131 | 36.309 | 36.916 | 37.468 | 9.872 | -0.054 | -0.058 |
| Total Equity
| 12.843 | 30.542 | 54.131 | 36.309 | 36.916 | 37.468 | 9.872 | -0.054 | -0.058 |
| Total Liabilities & Shareholders Equity
| 17.385 | 38.411 | 62.963 | 41.967 | 43.978 | 38.748 | 10.878 | 0.007 | 0.002 |